Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Refractory IBD
NCT02575040Phase 3Unknown
- Sponsor
- Gulhane School of Medicine
- Start
- May 2015
- Primary completion
- May 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of fecal microbiome transplant in ulcerative colitis (UC), Crohn's disease, sponsored by Gulhane School of Medicine. Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
ulcerative colitis (UC)Crohn's disease
Beyond the preview
Go deeper on NCT02575040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575040.